The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli

Infection and Immunity

Volumn 75, Issue 5, 2007, Pages 2189-2200

  Shimizu, Takeshi ^a   Kawakami, Satomi ^b,e   Sato, Toshio ^c   Sasaki, Terumi ^d   Higashide, Masato ^d   Hamabata, Takashi ^c   Ohta, Toshiko ^b   Noda, Masatoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d Kotobiken Medical Laboratories   (Japan)

^e ICAM Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; SERINE; VEROTOXIN 2;

ANIMAL EXPERIMENT; ARTICLE; CHIMERA; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TOXIN ANALYSIS;

ANIMALS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; GENE EXPRESSION REGULATION, BACTERIAL; MALE; MICE; MODELS, MOLECULAR; MUTATION; PROTEIN SUBUNITS; SERINE; SHIGA-LIKE TOXIN II;

EID: 34248392543     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01546-06     Document Type: Article

References (40)

1. Acheson, D. W., S. A. De Breucker, M. Jacewicz, L. L. Lincicome, A. Donohue-Rolfe, A. V. Kane, and G. T. Keusch. 1995. Expression and purification of Shiga-like toxin II B subunits. Infect. Immun. 63:301-308.
2. Acheson, D. W. K., A. Donohue-Rolfe, and G. T. Keusch. 1991. The family of Shiga and Shiga-like toxins, p. 415-433. In J. E. Alouf and J. H. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press Ltd., London, United Kingdom.
3. Chapon, V., H. D. Simpson, X. Morelli, E. Brun, and F. Barras. 2000. Alteration of a single tryptophan residue of the cellulose-binding domain blocks secretion of the Erwinia chrysanthemi Cel5 cellulase (ex-EGZ) via the type II system. J. Mol. Biol. 303:117-123.
4. Clark, C., D. Bast, A. M. Sharp, P. M. St. Hilaire, R. Agha, P. E. Stein, E. J. Toone, R. J. Read, and J. L. Brunton. 1996. Phenylalanine 30 plays an important role in receptor binding of verotoxin-1. Mol. Microbiol. 19:891-899.
5. Ebel, F., C. Deibel, A. U. Kresse, C. A. Guzman, and T. Chakraborty. 1996. Temperature- and medium-dependent secretion of proteins by Shiga toxin-producing Escherichia coli. Infect. Immun. 64:4472-4779.
6. Elliott, S. J., and J. B. Kaper. 1997. Role of type 1 fimbriae in EPEC infections. Microb. Pathog. 23:113-118.
7. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:45-50.
8. Finney, D. J. 1971. Probit analysis, 3rd ed. Cambridge University Press, London, United Kingdom.
9. Fraser, M. E., M. Fujinaga, M. M. Cherney, A. R. Melton-Celsa, E. M. Twiddy, A. D. O'Brien, and M. N. James. 2004. Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J. Biol. Chem. 279:27511-27517.
10. Griffin, P. M., S. M. Ostroff, R. V. Tauxe, K. D. Greene, J. G. Wells, J. H. Lewis, and P. A. Blake. 1988. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann. Intern. Med. 109:705-712.
11. Hirst, T. R., and J. Holmgren. 1987. Conformation of protein secreted across bacterial outer membranes: a study of enterotoxin translocation from Vibrio cholerae. Proc. Natl. Acad. Sci. USA 84:7418-7422.
12. Hirst, T. R., J. Sanchez, J. B. Kaper, S. J. Hardy, and J. Holmgren. 1984. Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli. Proc. Natl. Acad. Sci. USA 81:7752-7756.
13. Hofmann, S. L. 1993. Southwestern Internal Medicine Conference: Shiga-like toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura. Am. J. Med. Sci. 306:398-406.
14. Jackson, M. P., J. W. Newland, R. K. Holmes, and A. D. O'Brien. 1987. Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb. Pathog. 2:147-153.
15. Keusch, G. T., and D. W. Acheson. 1997. Thrombotic thrombocytopenic purpura associated with Shiga toxins. Semin. Hematol. 34:105-116.
16. Kleanthous, H., H. R. Smith, S. M. Scotland, R. J. Gross, B. Rowe, C. M. Taylor, and D. V. Milford. 1990. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: microbiological aspects. Arch. Dis. Child. 65:722-727.
17. Lansbury, L. E., and H. Ludlam. 1997. Escherichia coli O157: lessons from the past 15 years. J. Infect. 34:189-193.
18. Metcalf, W. W., W. Jiang, L. L. Daniels, S. K. Kim, A. Haldimann, and B. L. Wanner. 1996. Conditionally replicative and conjugative plasmids carrying lacZ alpha for cloning, mutagenesis, and allele replacement in bacteria. Plasmid 35:1-13.
19. Miyake, M., E. Utsuno, and M. Noda. 2000. Binding of avian ovomucoid to Shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography. Anal. Biochem. 281:202-208.
20. Nishikawa, K., K. Matsuoka, M. Watanabe, K. Igai, K. Hino, K. Hatano, A Yamada, N. Abe, D. Terunuma, H. Kuzuhara, and Y. Natori. 2005. Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation. J. Infect. Dis. 191:2097-2105.
21. Noda, M., T. Yutsudo, N. Nakabayashi, T. Hirayama, and Y. Takeda. 1987. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb. Pathog. 2:339-349.
22. O'Brien, A. D., and R. K. Holmes. 1987. Shiga and Shiga-like toxins. Microbiol. Rev. 51:206-220.
23. Ostroff, S. M., P. I. Tarr, M. A. Neill, J. H. Lewis, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160:994-998.
24. Perna, N. T., G. Plunkett III, V. Burland, B. Mau, J. D. Glasner, D. J. Rose, G. F. Mayhew, P. S. Evans, J. Gregor, H. A. Kirkpatrick, G. Posfai, J. Hackett, S. Klink, A. Boutin, Y. Shao, L. Miller, E. J. Grotbeck, N. W. Davis, A. Lim, E. T. Dimalanta, K. D. Potamousis, J. Apodaca, T. S. Anantharaman, J. Lin, G. Yen, D. C. Schwartz, R. A. Welch, and F. R. Blattner. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409:529-533.
25. Sandkvist, M. 2001. Biology of type II secretion. Mol. Microbiol. 40:271-283.
26. Sandkvist, M., L. O. Michel, L. P. Hough, V. M. Morales, M. Bagdasarian, M. Koomey, and V. J. DiRita. 1997. General secretion pathway (eps) genes required for toxin secretion and outer membrane biogenesis in Vibrio cholerae. J. Bacteriol. 179:6994-7003.
27. Simon, R., U. Priefer, and A. Pühler. 1982. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram-negative bacteria. Biotechnology 1:784-791.
28. Sixma, T. K., S. E. Pronk, K. H. Kalk, E. S. Wartna, B. A. van Zanten, B. Witholt, and W. G. Hol. 1991. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351:371-377.
29. Stein, P. E., A. Boodhoo, G. J. Tyrrell, J. L. Brunton, and R. J. Read. 1992. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature 355:748-750.
30. Strockbine, N. A., L. R. Marques, J. W. Newland, H. W. Smith, R. K. Holmes, and A. D. O'Brien. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
31. Tauschek, M., R. J. Gorrell, R. A. Strugnell, and R. M. Robins-Browne. 2002. Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc. Natl. Acad. Sci. USA 99:7065-7071.
32. Tesh, V. L., J. A. Burris, J. W. Owens, V. M. Gordon, E. A. Wadolkowski, A. D. O'Brien, and J. E. Samuel. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61:3392-3402.
33. Tesh, V. L., and A. D. O'Brien. 1991. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol. Microbiol. 5:1817-1822.
34. Wai, S. N., A. Takade, and K. Amako. 1995. The release of outer membrane vesicles from the strains of enterotoxigenic Escherichia coli. Microbiol. Immunol. 39:451-456.
35. Wanner, B. L. 1994. Gene expression in bacteria using TnphoA and TnphoA′ elements to make and switch phoA gene, lacZ(op), and lacZ(pr) fusions. Methods Mol. Genet. 3:291-310.
36. Weinstein, D. L., M. P. Jackson, L. P. Perera, R. K. Holmes, and A. D. O'Brien. 1989. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity. Infect. Immun. 57:3743-3750.
37. Wong, K. R., and J. T. Buckley. 1991. Site-directed mutagenesis of a single tryptophan near the middle of the channel-forming toxin aerolysin inhibits its transfer across the outer membrane of Aeromonas salmonicida. J. Biol. Chem. 266:14451-14456.
38. Yoh, M., E. K. Frimpong, and T. Honda. 1997. Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7. FEMS. Immunol. Med. Microbiol. 19:57-64.
39. Yutsudo, T., N. Nakabayashi, T. Hirayama, and Y. Takeda. 1987. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3:21-30.
40. Zhang, R. G., D. L. Scott, M. L. Westbrook, S. Nance, B. D. Spangler, G. G. Shipley, and E. M. Westbrook. 1995. The three-dimensional crystal structure of cholera toxin. J. Mol. Biol. 251:563-573.